BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

JSR Life Sciences Corporation Begins Beta Testing ExoCap™ for Exosome Elution and Purification


2/6/2013 2:06:00 PM

Sunnyvale, CA – Feb. 5, 2013 – JSR Life Sciences Corporation, announced today that ExoCap™, a complete kit based on the company’s Magnosphere™ magnetic particles and proprietary antibodies for the purification and elution of exosomes from serum, plasma, urine, and cell culture media, has begun beta testing. Exosome isolation is considered a highly promising technology for the non-invasive and early detection of cancer and infectious diseases. Exosomes are released from most cell types in the body including those that make up tissues and fluids. Because exosomes contain proteins and RNA, it is believed that isolating them from blood or urine samples can offer a window into the cells that compose other parts of the body such as organs and tissues.

“Exosome elution and purification has the potential to change how we diagnose some of the world’s worst diseases by helping us to identify them much earlier,” said Tim Lowery, Vice President of JSR Micro, JSR Life Sciences’ US distributor.

“Because the exosomes in blood or urine contain the same information as those in the kidneys, heart or lungs, we may be able to eliminate invasive biopsies and be able to detect these diseases much earlier in the diagnostic process.”

JSR Life Sciences’ magnetic bead-based ExoCap enables up to 77 percent faster and easier processing than ultracentrifuge and cleaner purification than precipitation methods. The solution also offers low nonspecific binding and the ability to elute intact exosomes. The ExoCap kit includes a stabilizer buffer, conjugated Magnosphere magnetic beads, a wash buffer and multiple elution buffers for a variety of downstream assays. ExoCap is being beta tested at major research facilities in the US.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES